Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Islas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Stem Cells (Dayton, Ohio)|January 27, 2005
Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesisPetra D Cravens, Michael W Melkus, Angela Padgett-Thomas, et al.
Journal of Virology|November 27, 2004
Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virusMiguel Islas-Ohlmayer, Angela Padgett-Thomas, Rana Domiati-Saad, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 2, 2004
Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shockBrian W Binck, May F Tsen, Miguel Islas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2010
Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamidePaul Shaughnessy, Miguel Islas-Ohlmayer, Julie Murphy, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|December 5, 2020
Outcomes of screening for gammopathies in children and adults with Gaucher disease type 1 in a cohort from Brazil and the United StatesKatherine Abell, Sarah E Chadwell, Thomas Andrew Burrow, et al.
Blood|July 19, 2003
Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitorsA Karolina Palucka, Joel Gatlin, Jean Philippe Blanck, et al.
Blood|April 29, 2018
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphomaAnn S LaCasce, R Gregory Bociek, Ahmed Sawas, et al.
Blood|December 2, 2024
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphomaHun Ju Lee, Rod Ramchandren, Judah Friedman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Stem Cells (Dayton, Ohio)|January 27, 2005
Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesisPetra D Cravens, Michael W Melkus, Angela Padgett-Thomas, et al.
Journal of Virology|November 27, 2004
Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virusMiguel Islas-Ohlmayer, Angela Padgett-Thomas, Rana Domiati-Saad, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 2, 2004
Bone marrow-derived cells contribute to contractile dysfunction in endotoxic shockBrian W Binck, May F Tsen, Miguel Islas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2010
Cost and clinical analysis of autologous hematopoietic stem cell mobilization with G-CSF and plerixafor compared to G-CSF and cyclophosphamidePaul Shaughnessy, Miguel Islas-Ohlmayer, Julie Murphy, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|December 5, 2020
Outcomes of screening for gammopathies in children and adults with Gaucher disease type 1 in a cohort from Brazil and the United StatesKatherine Abell, Sarah E Chadwell, Thomas Andrew Burrow, et al.
Blood|July 19, 2003
Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitorsA Karolina Palucka, Joel Gatlin, Jean Philippe Blanck, et al.
Blood|April 29, 2018
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphomaAnn S LaCasce, R Gregory Bociek, Ahmed Sawas, et al.
Blood|December 2, 2024
Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphomaHun Ju Lee, Rod Ramchandren, Judah Friedman, et al.
Pageof 1